Envarsus XR

Veloxis wins $1.3B buyout deal, and the new owner plans to follow up with new deals
Endpoints
Tue, 11/26/19 - 09:47 am
Asahi Kasei
Veloxis Pharmaceuticals
M&A
organ rejection
Envarsus XR
kidney transplants
FDA Accepts Veloxis’s Supplemental New Drug Application for Envarsus XR
CP Wire
Fri, 04/20/18 - 09:34 am
Veloxis Pharmaceuticals
Envarsus XR
kidney transplant
rejections
FDA Accepts Veloxis’s Supplemental New Drug Application for Envarsus XR
Thu, 04/19/18 - 11:31 pm
Veloxis Pharmaceuticals
Envarsus XR